Offer - Urjas Oil for just ₹ 1 X
Cetanil Trio 12.5 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Cetanil Trio 12.5 Tablet have also been mentioned below.
The optimal dosage of Cetanil Trio 12.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Cetanil Trio 12.5 Tablet also has some side effects, the most common being Back Pain, Loss of appetite, Gastric Irritation. Some other side effects of Cetanil Trio 12.5 Tablet have been listed ahead. These side effects of Cetanil Trio 12.5 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Cetanil Trio 12.5 Tablet's effect is Mild during pregnancy and Mild for lactating mothers. Warnings related to Cetanil Trio 12.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Cetanil Trio 12.5 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia as it can result in adverse effects. The section on Cetanil Trio 12.5 Tablet contraindications lists all such conditions.
Drug interactions for Cetanil Trio 12.5 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Cetanil Trio 12.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Cetanil Trio 12.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cetanil Trio 12.5 Tablet safe for pregnant women?
Cetanil Trio rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Cetanil Trio 12.5 Tablet safe during breastfeeding?
Side effects of Cetanil Trio on breastfeeding women are very mild.
What is the effect of Cetanil Trio 12.5 Tablet on the Kidneys?
Cetanil Trio rarely harms the kidneys.
What is the effect of Cetanil Trio 12.5 Tablet on the Liver?
Very few cases of side effects of Cetanil Trio on the liver have been reported.
What is the effect of Cetanil Trio 12.5 Tablet on the Heart?
Cetanil Trio is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Cetanil Trio 12.5 Tablet unless your doctor advises you to do so -
Is this Cetanil Trio 12.5 Tablet habit forming or addictive?
Forming a habit of Cetanil Trio 12.5 Tablet has not been reported.
Interaction between Food and Cetanil Trio 12.5 Tablet
Taking Cetanil Trio 12.5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Cetanil Trio 12.5 Tablet
Consumption of alcohol and Cetanil Trio 12.5 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448